MENU
MLYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mineralys Therapeutics (MLYS) Earnings Date & Reports
Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone... Show more
A.I. Advisor
published Earnings
MLYS is expected to report earnings to fall 73.68% to -75 cents per share on November 16
Q3'26
Est.
$-0.75
Q2'26
Missed
by $0.22
Q1'26
Beat
by $0.34
Q4'25
Beat
by $0.54
Q3'25
Beat
by $0.44
The last earnings report on August 11 showed earnings per share of -284 cents, missing the estimate of -263 cents. With 727.92K shares outstanding, the current market capitalization sits at 1.85B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
76
Web
https://mineralystx.com